NBMolecules: First Licence Agreement

Please login or
register
28.07.2015

NBMolecules has now signed its first License and Supply Agreement for one of its innovative products, with the MIS Implants Technologies Ltd, one of the world’s leading dental implant manufacturers.

MIS Implants Technologies Ltd and Nano Bridging Molecules SA announced today they have concluded a License and Supply Agreement for the advanced surface treatment technology SurfLink, manufactured by NBMolecules. “We are very proud of this commercial agreement with MIS, which will allow patients to benefit from the unique combination of a leading quality dental implant and a unique bio-mimicking surface” says Bjorn-Owe Aronsson, Executive Director and Founder of NBMolecules.

The agreement between the world leading dental implant company MIS and the start-up NBMolecules will give MIS the exclusive rights to manufacture and sell their titanium based dental implants with the clinically proven SurfLink surface. SurfLink consists of a permanently bound layer of phosphorous-rich molecules, which is applied to the implant surface to enhance osseointegration. The SurfLink surface is seen as bone-like by the body.

 

Clinical studies have shown SurfLink® maintains marginal bone levels over time, giving reproducible clinical results and predictable osseointegration.

MIS, a frontrunner of innovation, is committed to achieve the highest possible implant surface quality to give patients the best that science can offer. “This agreement with NBMolecules® is an important stage in our efforts to offer our customers real innovation, based on cutting edge and proven technology. It will allow us to give our dental surgeons access to truly world leading dental implants” says Idan Kleifeld, CEO of MIS.

About MIS Implants Technologies Ltd.
Established in 1995, MIS Implants Technologies Ltd. is a global leader in the development and production of advanced products and innovative solutions aimed to simplify implants dentistry. MIS is deeply committed to its core values of quality, service, agility and innovation, integrity and caring, reflected in every step of its work process and supported by over 400 dedicated MIS employees. MIS products are distributed in over 60 countries worldwide through a well-established global distribution network.

About Nano Bridging Molecules SA
NBMolecules, a privately held Swiss Medical Device company founded in 2002, is dedicated to developing and licensing out advanced surface treatments for bone anchored implants. NBMolecules is ISO 13485 certified and SurfLink is its first surface technology, which is manufactured in-house. SurfLink has been developed over a period of 15 years and has been proven to achieve true bone integration.

0Comments

More news about

Nano Bridging Molecules SA

Company profiles on startup.ch

Nano Bridging Molecules SA

rss